NIH to Retire Remaining Research Chimpanzees to Sanctuary
The National Institutes of Health is relocating its last group of research chimpanzees to a sanctuary, fulfilling a commitment made in 2015 to end biomedical research on chimpanzees. This move marks a significant shift in the treatment and use of animals in scientific research.
🧠AI AnalysisPhoto: statnews.com
Key points
- NIH to retire remaining research chimpanzees
- Chimpanzees to be relocated to a 200-acre sanctuary
- Move marks the end of an era in biomedical research
The US government's remaining research chimpanzees will soon be leaving their laboratory home behind. A total of nearly three dozen chimpanzees will be transferred to a sanctuary, marking the end of an era in biomedical research.
This decision comes after a long-standing commitment to retire all NIH-owned chimpanzees to sanctuary. The move is expected to take place early next year and will see the chimpanzees relocated to a 200-acre federal sanctuary.
What it means
The relocation of these chimpanzees is a significant step forward in the ethical treatment of animals in scientific research. However, it is essential to note that this decision is the result of a lengthy process and does not necessarily mark the end of animal testing in research.
The sanctuary, operated by Chimp Haven, will provide a safe and natural environment for the retired chimpanzees. The move is a positive step towards promoting animal welfare and raising awareness about the importance of treating animals with respect and care.
Source statnews.com — statnews.com/pharmalot/2026/11/18/nih-to-move-last-group-of-researc… ↗
Read next
❤️Conditions & CareBrepocitinib Shows Potential for Treating Cutaneous Sarcoidosis
A Phase II clinical trial indicates that the medication brepocitinib may significantly reduce disease activity in patients suffering from cutaneous sarcoidosis.
🔬ResearchJAK Inhibitor Shows Potential in Managing Immune Dysregulation in Down Syndrome
A phase 2 clinical trial indicates that the medication tofacitinib can safely reduce chronic immune overactivity in individuals with Down syndrome, leading to improvement…
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.